(3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 1g

4-(1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHYL)MORPHOLINE, 95.0%, 250mg

2-Amino-5-bromobenzotrifluoride, 98.0%, 100g

Ethyl 3-methylidenecyclobutane-1-carboxylate, 97% +(stabilized with MEHQ), 5g

Filtres pour seringues Polytétrafluoroéthylène hydrophobe (PTFE), 0,45 µm, 25 mm, non stérile, 100 pièce(s)

1-(4-Bromophenyl)-1h-pyrazole-3-carboxylic acid, 95%, 100mg

1,4-Dioxaspiro[4.5]decan-8-yl 4-methylbenzenesulfonate, 97%, 1g

6-Bromobenzo[d]isothiazole-3-carboxylic acid, 95.0%, 100mg

1-Bromo-2,3-bis(bromomethyl)benzene, 95.0%, 1g

3,3-Difluoro-5-nitroindolin-2-one, 98%, 100mg

4-Isobutylcyclohexane-1-carboxylic acid, 98%, 5g

2-Cyanomethyl-5-trifluoromethylpyridine, 95.0%, 10g

1-(pyrimidin-2-yl)piperidin-3-amine, 97%, 5g